Floatz logo

Therapeutic Asset Ratings

172 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bryostatin 1
Multiple Sclerosis
Robert FoxP1C (37)
Fludarabine Phosphate For
Multiple Sclerosis
St. Petersburg State Pavlov Medical UniversityP1C (37)
Foralumab
Multiple Sclerosis
Tiziana Life Sciences LTDP1C (37)
Glibenclamide
Multiple Sclerosis
University of Maryland, BaltimoreP1C (37)
Idp-023
Multiple Sclerosis
Indapta Therapeutics, INC.P1C (37)
ims001
Multiple Sclerosis
ImStem BiotechnologyP1C (37)
Intranasal Foralumab
Multiple Sclerosis
Tiziana Life Sciences LTDP1C (37)
Ipilimumab
Multiple Sclerosis
National Cancer Institute (NCI)P1C (37)
ivl3004
Multiple Sclerosis
Inventage Lab., Inc.P1C (37)
ivl4002
Multiple Sclerosis
Inventage Lab., Inc.P1C (37)
Kite-363
Multiple Sclerosis
Kite, A Gilead CompanyP1C (37)
Lu Ag06466
Multiple Sclerosis
H. Lundbeck A/SP1C (37)
Nivolumab
Multiple Sclerosis
National Cancer Institute (NCI)P1C (37)
Ocrelizumab Co-Formulated With Rhuph20
Multiple Sclerosis
Hoffmann-La RocheP1C (37)
Orca-Q
Multiple Sclerosis
Stanford UniversityP1C (37)
P-Cd19Cd20-Allo1 Cells
Multiple Sclerosis
Genentech, Inc.P1C (37)
RO7121932
Multiple Sclerosis
Hoffmann-La RocheP1C (37)
Rph-035
Multiple Sclerosis
R-PharmP1C (37)
s103 cells
Multiple Sclerosis
Xijing HospitalP1C (37)
Thiotepa
Multiple Sclerosis
Stanford UniversityP1C (37)
Vancomycin
Multiple Sclerosis
Icahn School of Medicine at Mount SinaiP1C (37)
Zirconium Zr 89 Crefmirlimab Berdoxam
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS)P1C (37)
ad26.cov2.s
Multiple Sclerosis
Griffin HospitalEarly P1C (34)
ct103a cells
Multiple Sclerosis
Tongji HospitalEarly P1C (34)
Gentamycin
Multiple Sclerosis
Medstar Health Research InstituteEarly P1C (34)
Showing 126 to 150 of 172 assets
PreviousPage 6 of 7Next